Logo-bma
Biomed adv. 2026;3(3): 111-116. doi: 10.34172/bma.72

Original Article

Unveiling Retinal Effects of SGLT2 Inhibition: A Retrospective Analysis of Empagliflozin on Macular Thickness in Type 2 Diabetes with Macular Edema

Neda Lotfi Yagin 1 ORCID, Naimeh Mesri Alamdari 2, Siamak Khavandi 2, Soghra Aliasgharzadeh 3, Alireza Ostadrahimi 3, Majid Mobasseri 2 * ORCID

Cited by CrossRef:


Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with